HomeIPHA • NASDAQ
Innate Pharma SA
$1.44
Nov 15, 8:30:00 PM GMT-5 · USD · NASDAQ · Disclaimer
US listed security
Previous close
$1.63
Day range
$1.44 - $1.66
Year range
$1.44 - $3.15
Market cap
112.39M USD
Avg Volume
9.14K
Financials
Income Statement
Revenue
Net income
(EUR)Jun 2024Y/Y change
Revenue
6.17M-69.29%
Operating expense
4.79M4.79%
Net income
-12.38M-1,541.44%
Net profit margin
-200.60-4,797.89%
Earnings per share
EBITDA
-12.78M-1,007.13%
Effective tax rate
Total assets
Total liabilities
(EUR)Jun 2024Y/Y change
Cash and short-term investments
91.80M3.27%
Total assets
151.50M-23.89%
Total liabilities
122.70M-13.09%
Total equity
28.80M
Shares outstanding
80.95M
Price to book
4.53
Return on assets
-21.71%
Return on capital
-51.15%
Net change in cash
(EUR)Jun 2024Y/Y change
Net income
-12.38M-1,541.44%
Cash from operations
1.52M126.48%
Cash from investing
466.00K478.86%
Cash from financing
-2.16M-247.27%
Net change in cash
-307.50K95.20%
Free cash flow
-7.03M-428.30%
About
Founded
1999
Employees
168
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu